Cross-tissue Analysis of Gene and Protein Expression in Normal and Cancer Tissues

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kosti, Idit ^a   Jain, Nishant ^a   Aran, Dvir ^a   Butte, Atul J ^a   Sirota, Marina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; PROTEOME;

BLADDER; BLADDER TUMOR; FACTUAL DATABASE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS;

BIOMARKERS; DATABASES, FACTUAL; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; PROTEOME; RNA, MESSENGER; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84966272945     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24799     Document Type: Article

References (32)

1. Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10, 57-63, doi: 10.1038/nrg2484 (2009).
2. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5, 621-628, doi: 10.1038/nmeth.1226 (2008).
3. Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580-585, doi: 10.1038/ng.2653 (2013).
4. Bell, A. W. et al. A HUPO test sample study reveals common problems in mass spectrometry-based proteomics. Nat Methods 6, 423-430, doi: 10.1038/nmeth.1333 (2009).
5. Aebersold, R. & Mann, M. Mass spectrometry-based proteomics. Nature 422, 198-207, doi: 10.1038/nature01511 (2003).
6. Greenbaum, D., Colangelo, C., Williams, K. & Gerstein, M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4, 117, doi: 10.1186/gb-2003-4-9-117 (2003).
7. Lundberg, E. et al. Defining the transcriptome and proteome in three functionally different human cell lines. Mol Syst Biol 6, 450, doi: 10.1038/msb.2010.106 (2010).
8. Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419, doi: 10.1126/science.1260419 (2015).
9. Vogel, C. & Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13, 227-232, doi: 10.1038/nrg3185 (2012).
10. Gygi, S. P., Rochon, Y., Franza, B. R. & Aebersold, R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19, 1720-1730 (1999).
11. Schwanhausser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337-342, doi: 10.1038/nature10098 (2011).
12. Gry, M. et al. Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics 10, 365, doi: 10.1186/1471-2164-10-365 (2009).
13. Chen, G. et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1, 304-313 (2002).
14. Kim, M. S. et al. A draft map of the human proteome. Nature 509, 575-581, doi: 10.1038/nature13302 (2014).
15. Wilhelm, M. et al. Mass-spectrometry-based draft of the human proteome. Nature 509, 582-587, doi: 10.1038/nature13319 (2014).
16. Mele, M. et al. Human genomics. The human transcriptome across tissues and individuals. Science 348, 660-665, doi: 10.1126/science.aaa0355 (2015).
17. Sassone-Corsi, P. Unique chromatin remodeling and transcriptional regulation in spermatogenesis. Science 296, 2176-2178, doi: 10.1126/science.1070963 (2002).
18. Colantuoni, C. et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519-523, doi: 10.1038/nature10524 (2011).
19. Huillet, C. et al. Accurate quantification of cardiovascular biomarkers in serum using Protein Standard Absolute Quantification (PSAQ) and selected reaction monitoring. Mol Cell Proteomics 11, M111 008235, doi: 10.1074/mcp.M111.008235 (2012).
20. Zeng, G. Q. et al. Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics. Mol Cell Proteomics 11, M111 013946, doi: 10.1074/mcp.M111.013946 (2012).
21. Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42, D1091-1097, doi: 10.1093/nar/gkt1068 (2014).
22. Li, J. et al. TCPA: a resource for cancer functional proteomics data. Nat Methods 10, 1046-1047, doi: 10.1038/nmeth.2650 (2013).
23. Homer, C. et al. Y-box factor YB1 controls p53 apoptotic function. Oncogene 24, 8314-8325, doi: 10.1038/sj.onc.1208998 (2005).
24. Jurchott, K. et al. Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells. PLoS Genet 6, e1001231, doi: 10.1371/journal.pgen.1001231 (2010).
25. Yan, X. B. et al. Knockdown of Yboxbinding protein1 inhibits the malignant progression of HT29 colorectal adenocarcinoma cells by reversing epithelialmesenchymal transition. Mol Med Rep 10, 2720-2728, doi: 10.3892/mmr.2014.2545 (2014).
26. Lasham, A. et al. YB-1, the E2F pathway, and regulation of tumor cell growth. J Natl Cancer Inst 104, 133-146, doi: 10.1093/jnci/djr512 (2012).
27. Goodarzi, H. et al. Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement. Cell 161, 790-802, doi: 10.1016/j.cell.2015.02.053 (2015).
28. Nilsen, T. W. & Graveley, B. R. Expansion of the eukaryotic proteome by alternative splicing. Nature 463, 457-463, doi: 10.1038/nature08909 (2010).
29. Ahlin, G. et al. Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs. Drug Metab Dispos 37, 2275-2283, doi: 10.1124/dmd.109.028654 (2009).
30. Suzuki, R. & Shimodaira, H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22, 1540-1542, doi: 10.1093/bioinformatics/btl117 (2006).
31. Dennis, G. Jr. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3 (2003).
32. Supek, F., Bosnjak, M., Skunca, N. & Smuc, T. REVIGO summarizes and visualizes long lists of gene ontology terms. Plos One 6, e21800, doi: 10.1371/journal.pone.0021800 (2011).